These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 35568286)

  • 1. Lymph node ratio-dependent prognosis stratification and postoperative radiotherapy utilization in T1-2N1 oral cavity carcinoma.
    Wang J; Liu Y; Shayan G; Ma Y; Yi J
    Radiother Oncol; 2022 Jul; 172():83-90. PubMed ID: 35568286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of lymph node ratio to guide clinical decision-making concerning adjuvant radiotherapy in pT1-2N1 rectal cancer.
    Luo D; Ye Z; Zhang R; Li Q; Li X
    Int J Colorectal Dis; 2023 May; 38(1):115. PubMed ID: 37148381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing Prognostic Value of Quantitative Neck Dissection Quality Measures in Patients With Clinically Node-Negative Oral Cavity Squamous Cell Carcinoma.
    Farrokhian N; Holcomb AJ; Dimon E; Karadaghy O; Ward C; Whiteford E; Tolan C; Hanly EK; Buchakjian MR; Harding B; Dooley L; Shinn J; Wood CB; Rohde S; Khaja S; Parikh A; Bulbul MG; Penn J; Goodwin S; Bur AM
    JAMA Otolaryngol Head Neck Surg; 2022 Oct; 148(10):947-955. PubMed ID: 36074415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymph node ratio relationship to regional failure and distant metastases in oral cavity cancer.
    Hosni A; McMullen C; Huang SH; Xu W; Su J; Bayley A; Bratman SV; Cho J; Giuliani M; Kim J; Ringash J; Waldron J; Spreafico A; Weinreb I; de Almeida JR; Brown DH; Irish JC; O'Sullivan B; Goldstein DP; Hope A
    Radiother Oncol; 2017 Aug; 124(2):225-231. PubMed ID: 28838425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of lymph node ratio in patients with squamous cell carcinoma of the floor of the mouth.
    Liu XC; Ma SR; Shi S; Zhao YF; Jia J
    Int J Oral Maxillofac Surg; 2022 Mar; 51(3):307-313. PubMed ID: 34281747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the prognostic value of lymph node yield, lymph node ratio, and number of lymph node metastases in patients with oral squamous cell carcinoma.
    Struckmeier AK; Buchbender M; Lutz R; Agaimy A; Kesting M
    Head Neck; 2024 May; 46(5):1083-1093. PubMed ID: 38501325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of lymph node ratio on survival and recurrence outcomes in oral squamous cell carcinoma.
    Mamic M; Lucijanic M; Lorencin M; Suton P; Luksic I
    Int J Oral Maxillofac Surg; 2022 Oct; 51(10):1257-1263. PubMed ID: 35101318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node ratio predicts the benefit of post-operative radiotherapy in oral cavity cancer.
    Urban D; Gluck I; Pfeffer MR; Symon Z; Lawrence YR
    Radiother Oncol; 2013 Jan; 106(1):74-9. PubMed ID: 23157979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved prognostic stratification of patients with pN3b oral cavity cancer based on maximum standardized uptake value of metastatic nodes, lymph node ratio, and level of cervical nodal metastases.
    Cheng NM; Kang CJ; Tsai CY; Lee LY; Lin CY; Hsueh C; Fan KH; Wang HM; Hsieh CH; Ng SH; Yeh CH; Lin CH; Tsao CK; Fang TJ; Huang SF; Lee LA; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Liao CT
    Oral Oncol; 2021 Dec; 123():105593. PubMed ID: 34768211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Lymph Node Ratio a Prognostic Factor for Patients With Oral Squamous Cell Carcinoma?
    Yamagata K; Fukuzawa S; Kanno N; Uchida F; Yanagawa T; Bukawa H
    J Oral Maxillofac Surg; 2019 Jul; 77(7):1510-1519. PubMed ID: 30822404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Lymph Node Ratio and Recurrence and Survival Outcomes in Patients With Oral Cavity Cancer.
    Ding D; Stokes W; Eguchi M; Hararah M; Sumner W; Amini A; Goddard J; Somerset H; Bradley C; McDermott J; Raben D; Karam SD
    JAMA Otolaryngol Head Neck Surg; 2019 Jan; 145(1):53-61. PubMed ID: 30452499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between lymph node ratio and survival outcomes in patients with oral squamous cell carcinoma.
    Haraguchi K; Habu M; Takahashi O; Tominaga K; Yoshioka I; Sasaguri M
    J Stomatol Oral Maxillofac Surg; 2024 Jun; 125(3S):101816. PubMed ID: 38458548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph node ratio as a predictor for outcome in oral squamous cell carcinoma: a multicenter population-based cohort study.
    Spoerl S; Gerken M; Mamilos A; Fischer R; Wolf S; Nieberle F; Klingelhöffer C; Meier JK; Spoerl S; Ettl T; Reichert TE; Spanier G
    Clin Oral Investig; 2021 Apr; 25(4):1705-1713. PubMed ID: 32754787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node ratio precisely predicts the benefit of postoperative radiotherapy in esophageal cancer: A retrospective cohort study.
    Liang Y; Jian Q; Deng MG; Yi Z; Peng C; Lu C; Yang H; Liu J
    Asian J Surg; 2023 Sep; 46(9):3680-3686. PubMed ID: 37059676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph node ratio as a prognostic factor in head and neck cancer patients.
    Chen CC; Lin JC; Chen KW
    Radiat Oncol; 2015 Aug; 10():181. PubMed ID: 26302761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential of lymph-node ratio as a prognostic factor for patients with oral squamous cell carcinoma.
    Tomo S; Araújo WAF; de Castro TF; Neto SC; Collado FU; Biasoli ÉR; Bernabé DG; Miyahara GI
    J Stomatol Oral Maxillofac Surg; 2022 Nov; 123(6):e814-e821. PubMed ID: 35998818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of adjuvant radiotherapy on survival in T1-2N1 squamous cell carcinoma of the oral cavity.
    Shrime MG; Gullane PJ; Dawson L; Kim J; Gilbert RW; Irish JC; Brown DH; Goldstein DP
    Arch Otolaryngol Head Neck Surg; 2010 Mar; 136(3):225-8. PubMed ID: 20231637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of lymph node ratio and number of lymph node metastases on survival and recurrence in laryngeal squamous cell carcinoma.
    Molteni G; Nocini R; Mattioli F; Nakayama M; Dedivitis RA; Mannelli G; Crosetti E; Chiesa-Estomba CM; Sistiaga-Suarez JA; Giordano L; Galli A; Lionello M; Mercante G; Ralli M; Fermi M; Klein-Rodríguez A; Mayo-Yáñez M; Serafini E; Pirola F; Paderno A; Cambria F; Oridate N; Sano D; Boscolo-Rizzo P; Marcuzzo AV; Parrinello G; Marchi F; Saibene AM; Tucciarone M; Viscasillas G; Zeleník K; Ramos DM; Palacios-Garcia J; Tirelli G; Pellini R; Paludetti G; Galli J; Rossi G; De Vincentiis M; Cernea CR; Spriano G; Bussi M; Peretti G; Succo G; Piazza C; Bertolin A; Kowalski LP; Presutti L; Sacchetto A
    Head Neck; 2023 Sep; 45(9):2274-2293. PubMed ID: 37496499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of lymph node involvement in oral squamous cell carcinoma.
    Voss JO; Freund L; Neumann F; Mrosk F; Rubarth K; Kreutzer K; Doll C; Heiland M; Koerdt S
    Clin Oral Investig; 2022 Nov; 26(11):6711-6720. PubMed ID: 35895143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is elective neck dissection justified in cT2N0M0 oral cavity cancer defined according to the AJCC eighth edition staging system?
    Chen TM; Terng SD; Lee LY; Lee SR; Ng SH; Kang CJ; Lin JC; Chien CY; Hua CH; Wang CP; Chen WC; Tsai YT; Tsai CY; Lin CY; Fan KH; Wang HM; Hsieh CH; Yeh CH; Lin CH; Tsao CK; Cheng NM; Fang TJ; Huang SF; Lee LA; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Wen YW; Liao CT
    Cancer Med; 2024 Jan; 13(1):e6894. PubMed ID: 38169115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.